Raffles Medical Group (FRA:02M1) YoY EBITDA Growth : -53.06% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Raffles Medical Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Raffles Medical Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -53.06%.

Raffles Medical Group's EBITDA per Share for the six months ended in Dec. 2023 was €0.02.

Raffles Medical Group YoY EBITDA Growth Historical Data

The historical data trend for Raffles Medical Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raffles Medical Group YoY EBITDA Growth Chart

Raffles Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

5.41

7.69

33.33

58.93

-32.58

Raffles Medical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															11.11	56.00	63.33	-5.13	-53.06

Raffles Medical Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Raffles Medical Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.06	-	0.089)	/	\| 0.089 \|
=	-32.58 %

Raffles Medical Group's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0.023	-	0.049)	/	\| 0.049 \|
=	-53.06 %

Raffles Medical Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Raffles Medical Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Raffles Medical Group (FRA:02M1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Raffles Medical Group Ltd (FRA:02M1) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

RAFLF:USA BSL:Singapore

Address

585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770

Website

https://www.rafflesmedicalgroup.com

Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The Hospital services segment provides medical services and operates hospitals, medical laboratories, and imaging centers. The Healthcare Services segment operates medical clinics and other general medical services, provides health insurance, trades pharmaceutical and nutraceutical products and diagnostic equipment, and provides management and consultancy services. The Investment holding segment involves investment in properties.

Raffles Medical Group (FRA:02M1) Headlines

No Headlines